From September 24, 2021 post.
GOP Doctors Caucus members Reps. Scott DesJarlais, M.D., (R-Tenn.) and Buddy Carter, R.Ph., (R-Ga.) led members of House Republican Conference, including Leader Kevin McCarthy (R-Calif.) and Conference Chair Elise Stefanik (R-N.Y.), in writing to Secretary of Health and Human Services Secretary Xavier Becerra, expressing concerns about a recent decision to transition monoclonal antibody distribution from a direct ordering process to a federally controlled distribution process.
“This change in distribution threatens to reduce or delay access to this life saving therapy for the patients who need it most. Additionally, a slight delay in administration of this therapy could be fatal. As you know, providers and health systems are already required to report mAb distribution data to HHS. The federal government should not hinder the efforts of providers seeking to procure and administer this product. Disallowing direct supply of mAb while a new distribution system is being developed will cause further delays,” the members wrote.
Original source can be found here.
